Literature DB >> 21244350

Determination of spatial and temporal distribution of microglia by 230nm-high-resolution, high-throughput automated analysis reveals different amyloid plaque populations in an APP/PS1 mouse model of Alzheimer's disease.

Katja Scheffler1, Jan Stenzel, Markus Krohn, Cathleen Lange, Jacqueline Hofrichter, Toni Schumacher, Thomas Brüning, Anne-Sophie Plath, Lary Walker, Jens Pahnke.   

Abstract

One early and prominent pathologic feature of Alzheimer's disease (AD) is the appearance of activated microglia in the vicinity of developing β-amyloid deposits. However, the precise role of microglia during the course of AD is still under discussion. Microglia have been reported to degrade and clear β-amyloid, but they also can exert deleterious effects due to overwhelming inflammatory reactions. Here, we demonstrate the occurrence of developing plaque populations with distinct amounts of associated microglia using time-dependent analyses of plaque morphology and the spatial distribution of microglia in an APP/PS1 mouse model. In addition to a population of larger plaques (>700µm(2)) that are occupied by a moderate contingent of microglial cells across the course of aging, a second type of small β-amyloid deposits develops (≤400µm(2)) in which the plaque core is enveloped by a relatively large number of microglia. Our analyses indicate that microglia are strongly activated early in the emergence of senile plaques, but that activation is diminished in the later stages of plaque evolution (>150 days). These findings support the view that microglia serve to restrict the growth of senile plaques, and do so in a way that minimizes local inflammatory damage to other components of the brain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21244350      PMCID: PMC3117051          DOI: 10.2174/156720511797633179

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  38 in total

1.  Biochemical identification of the neutral endopeptidase family member responsible for the catabolism of amyloid beta peptide in the brain.

Authors:  Y Takaki; N Iwata; S Tsubuki; S Taniguchi; S Toyoshima; B Lu; N P Gerard; C Gerard; H J Lee; K Shirotani; T C Saido
Journal:  J Biochem       Date:  2000-12       Impact factor: 3.387

2.  Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization.

Authors:  J-M Orgogozo; S Gilman; J-F Dartigues; B Laurent; M Puel; L C Kirby; P Jouanny; B Dubois; L Eisner; S Flitman; B F Michel; M Boada; A Frank; C Hock
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

Review 3.  The role of microglia in antibody-mediated clearance of amyloid-beta from the brain.

Authors:  Dave Morgan
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-03       Impact factor: 4.388

4.  Brain glia release factors with opposing actions upon neuronal survival.

Authors:  D Giulian; K Vaca; M Corpuz
Journal:  J Neurosci       Date:  1993-01       Impact factor: 6.167

5.  The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease.

Authors:  Silke Vogelgesang; Rolf W Warzok; Ingolf Cascorbi; Christiane Kunert-Keil; Eike Schroeder; Heyo K Kroemer; Werner Siegmund; Lary C Walker; Jens Pahnke
Journal:  Curr Alzheimer Res       Date:  2004-05       Impact factor: 3.498

6.  Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry.

Authors:  E Kunisch; R Fuhrmann; A Roth; R Winter; W Lungershausen; R W Kinne
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

7.  Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice.

Authors:  Suzanne E Hickman; Elizabeth K Allison; Joseph El Khoury
Journal:  J Neurosci       Date:  2008-08-13       Impact factor: 6.167

8.  Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.

Authors:  Rea Pihlaja; Jari Koistinaho; Tarja Malm; Herkko Sikkilä; Seppo Vainio; Milla Koistinaho
Journal:  Glia       Date:  2008-01-15       Impact factor: 7.452

Review 9.  Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms.

Authors:  Magdalena Sastre; Thomas Klockgether; Michael T Heneka
Journal:  Int J Dev Neurosci       Date:  2006-02-10       Impact factor: 2.457

Review 10.  Microglial clearance function in health and disease.

Authors:  I Napoli; H Neumann
Journal:  Neuroscience       Date:  2008-07-01       Impact factor: 3.590

View more
  16 in total

1.  Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice.

Authors:  Markus Krohn; Cathleen Lange; Jacqueline Hofrichter; Katja Scheffler; Jan Stenzel; Johannes Steffen; Toni Schumacher; Thomas Brüning; Anne-Sophie Plath; Franziska Alfen; Anke Schmidt; Felix Winter; Katja Rateitschak; Andreas Wree; Jörg Gsponer; Lary C Walker; Jens Pahnke
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

Review 2.  Monocytes in health and disease - Minireview.

Authors:  K R Karlmark; F Tacke; I R Dunay
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-06-13

3.  Perfusion single photon emission computed tomography in a mouse model of neurofibromatosis type 1: towards a biomarker of neurologic deficits.

Authors:  Ivayla Apostolova; Dagmara Niedzielska; Thorsten Derlin; Eva J Koziolek; Holger Amthauer; Benedikt Salmen; Jens Pahnke; Winfried Brenner; Victor F Mautner; Ralph Buchert
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-18       Impact factor: 6.200

4.  Spinal cord pathology in chronic experimental Toxoplasma gondii infection.

Authors:  L Möhle; A Parlog; J Pahnke; I R Dunay
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-03-14

5.  Reduced Alzheimer's disease pathology by St. John's Wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice.

Authors:  Jacqueline Hofrichter; Markus Krohn; Toni Schumacher; Cathleen Lange; Björn Feistel; Bernd Walbroel; Hans-Jochen Heinze; Sara Crockett; Timothy F Sharbel; Jens Pahnke
Journal:  Curr Alzheimer Res       Date:  2013-12       Impact factor: 3.498

6.  Mitochondrial DNA polymorphisms specifically modify cerebral β-amyloid proteostasis.

Authors:  Katja Scheffler; Markus Krohn; Tina Dunkelmann; Jan Stenzel; Bruno Miroux; Saleh Ibrahim; Oliver von Bohlen Und Halbach; Hans-Jochen Heinze; Lary C Walker; Jörg A Gsponer; Jens Pahnke
Journal:  Acta Neuropathol       Date:  2012-04-18       Impact factor: 17.088

7.  Genomic background-related activation of microglia and reduced β-amyloidosis in a mouse model of Alzheimer's disease.

Authors:  Christina Fröhlich; Kristin Paarmann; Johannes Steffen; Jan Stenzel; Markus Krohn; Hans-Jochen Heinze; Jens Pahnke
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-03-01

8.  ABC transporters B1, C1 and G2 differentially regulate neuroregeneration in mice.

Authors:  Toni Schumacher; Markus Krohn; Jacqueline Hofrichter; Cathleen Lange; Jan Stenzel; Johannes Steffen; Tina Dunkelmann; Kristin Paarmann; Christina Fröhlich; Annekathrin Uecker; Anne-Sophie Plath; Alexandra Sommer; Thomas Brüning; Hans-Jochen Heinze; Jens Pahnke
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

Review 9.  Neuroinflammation in Alzheimer's disease.

Authors:  Fengjin Zhang; Linlan Jiang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-01-30       Impact factor: 2.570

10.  Chronic Toxoplasma gondii infection enhances β-amyloid phagocytosis and clearance by recruited monocytes.

Authors:  Luisa Möhle; Nicole Israel; Kristin Paarmann; Markus Krohn; Sabine Pietkiewicz; Andreas Müller; Inna N Lavrik; Jeffrey S Buguliskis; Björn H Schott; Dirk Schlüter; Eckart D Gundelfinger; Dirk Montag; Ulrike Seifert; Jens Pahnke; Ildiko Rita Dunay
Journal:  Acta Neuropathol Commun       Date:  2016-03-16       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.